HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tatiana Caccia Selected Research

palosentron drug combination netupitant

11/2019Pharmacokinetic profile and safety of intravenous NEPA, a fixed combination of fosnetupitant and palonosetron, in cancer patients: Prevention of chemotherapy-induced nausea and vomiting associated with highly emetogenic chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tatiana Caccia Research Topics

Disease

1Constipation
11/2019
1Nausea
11/2019
1Neoplasms (Cancer)
11/2019
1Vomiting
11/2019

Drug/Important Bio-Agent (IBA)

1palosentron drug combination netupitantIBA
11/2019
1netupitantIBA
11/2019
1Palonosetron (Aloxi)FDA Link
11/2019
1ProdrugsIBA
11/2019

Therapy/Procedure

1Drug Therapy (Chemotherapy)
11/2019